Wednesday, April 2, 2014

AFREZZA® - A First-in-class Ultra Rapid-Acting Insulin - Inhaled insulin

AFREZZA® - A First-in-class Ultra Rapid-Acting Insulin - Inhaled insulin



FDA Advisory Panel Votes in Favor of Inhaled Insulin Device

No comments:

Post a Comment